Cargando…

Increased serum levels of mutant p53 proteins in patients with colorectal cancer.

We have examined the serum levels of the mutant p53 protein in patients with colorectal cancer preoperatively (n=50), and in patients with adenomatous polyp (n=13). Mutant p53 protein in patients after curative surgical resection of colorectal cancer (n=26, part of the fifty preoperative patients) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, K. S., Kim, K. H., Park, B. W., Lee, S. Y., Choi, J. H., Han, W. S., Park, E. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Academy of Medical Sciences 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054335/ https://www.ncbi.nlm.nih.gov/pubmed/9539318

Ejemplares similares

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.
por: Kressner, U., et al.
Publicado: (1998)

p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
por: Choi, S. W., et al.
Publicado: (1994)

An immunohistochemical study of the expression of p53 protein in colon cancer.
por: Kim, Y. W., et al.
Publicado: (1995)

Increased p53 protein content of colorectal tumours correlates with poor survival.
por: Remvikos, Y., et al.
Publicado: (1992)

P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
por: De Angelis, P., et al.
Publicado: (1995)

Growth Inhibition by Anchorage‐deficiency Is Associated with Increased Level but Reduced Phosphorylation of Mutant p53
por: Takahashi, Kazuhide, et al.
Publicado: (1992)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

The Increased Level of Serum p53 in Hepatitis B-Associated Liver Cirrhosis
por: Shahnazari, Parisa, et al.
Publicado: (2014)

Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis.
por: Cho, J. H., et al.
Publicado: (2000)

Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
por: Jang, W. I., et al.
Publicado: (1993)

p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020)

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
por: Solomon, Hilla, et al.
Publicado: (2018)

Regulation of Mutant p53 Protein Expression
por: Vijayakumaran, Reshma, et al.
Publicado: (2015)

Mutant p53 mediates survival of breast cancer cells
por: Lim, L Y, et al.
Publicado: (2009)

Mutant p53 in cell-cell interactions
por: Pilley, Steven, et al.
Publicado: (2021)

Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
por: Li, Hui, et al.
Publicado: (2019)

Mutant p53 as an Antigen in Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2020)

Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
por: Park, E K, et al.
Publicado: (2015)

p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53
por: Yan, H, et al.
Publicado: (2015)

Mutant p53: it’s not all one and the same
por: Kennedy, Margaret C., et al.
Publicado: (2022)

Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation
por: Naus, Evelyne, et al.
Publicado: (2023)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Functional interplay between MDM2, p63/p73 and mutant p53
por: Stindt, M H, et al.
Publicado: (2015)

Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
por: Goh, Amanda M., et al.
Publicado: (2015)

Big bones in p53 mutants
por: LeBrasseur, Nicole
Publicado: (2006)

Mutant p53 succumbs to starvation
por: Moon, Sung-Hwan, et al.
Publicado: (2013)

Chromatin dysregulation by mutant p53
por: Pfister, Neil T., et al.
Publicado: (2016)

Mutant p53 partners in crime
por: Kim, Michael P, et al.
Publicado: (2018)

Mutant p53 in colon cancer
por: Nakayama, Mizuho, et al.
Publicado: (2018)

Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
por: Slatter, T L, et al.
Publicado: (2015)

Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
por: Cho, H., et al.
Publicado: (1999)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

Selective in vitro cytotoxicity effect of Drimia calcarata bulb extracts against p53 mutant HT-29 and p53 wild-type Caco-2 colorectal cancer cells through STAT5B regulation
por: Laka, K., et al.
Publicado: (2021)

Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment
por: Wong, G S, et al.
Publicado: (2013)

p53 tetramerization: at the center of the dominant-negative effect of mutant p53
por: Gencel-Augusto, Jovanka, et al.
Publicado: (2020)

Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance
por: Aramayo, Ricardo, et al.
Publicado: (2011)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
por: Yue, Xuetian, et al.
Publicado: (2015)

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
por: Zhang, Yaqun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iff88qdqnd2995lr4ek0u6of9l